A detailed history of Financial Advisory Service, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Advisory Service, Inc. holds 2,664 shares of AZN stock, worth $174,838. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,664
Previous 2,650 0.53%
Holding current value
$174,838
Previous $206,000 0.49%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$76.67 - $87.62 $1,073 - $1,226
14 Added 0.53%
2,664 $207,000
Q2 2024

Jul 29, 2024

BUY
$66.81 - $80.83 $177,046 - $214,199
2,650 New
2,650 $206,000
Q1 2023

May 11, 2023

SELL
$63.15 - $71.6 $3,031 - $3,436
-48 Reduced 0.74%
6,417 $445,000
Q4 2022

Feb 01, 2023

BUY
$54.21 - $70.44 $4,119 - $5,353
76 Added 1.19%
6,465 $438,000
Q3 2022

Oct 20, 2022

BUY
$53.02 - $135.75 $795 - $2,036
15 Added 0.24%
6,389 $350,000
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $1,560 - $1,879
28 Added 0.44%
6,374 $423,000
Q4 2021

Feb 11, 2022

BUY
$54.02 - $63.83 $24,579 - $29,042
455 Added 7.72%
6,346 $370,000
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $23,835 - $26,078
429 Added 7.85%
5,891 $354,000
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $565 - $653
12 Added 0.22%
5,462 $272,000
Q4 2020

Feb 10, 2021

BUY
$48.52 - $58.02 $18,486 - $22,105
381 Added 7.52%
5,450 $272,000
Q3 2020

Nov 16, 2020

BUY
$53.07 - $61.1 $212 - $244
4 Added 0.08%
5,069 $278,000
Q1 2020

May 14, 2020

BUY
$37.79 - $51.33 $491 - $667
13 Added 0.26%
5,065 $226,000
Q3 2019

Nov 06, 2019

BUY
$40.12 - $45.47 $202,686 - $229,714
5,052 New
5,052 $225,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Financial Advisory Service, Inc. Portfolio

Follow Financial Advisory Service, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisory Service, Inc. with notifications on news.